Samuel Agresta - 16 Aug 2023 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Chief Medical Officer
Signature: /s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol: FHTX
Transactions as of: 16 Aug 2023
Transactions value $: -$1,410,175
Form type: 4
Filing time: 18 Aug 2023, 17:03:38 UTC
Previous filing: 30 Jan 2023
Next filing: 13 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FHTX	Common Stock	Options Exercise	$1.16M	+311K		$3.72	311K	16 Aug 2023	Direct
transaction	FHTX	Common Stock	Sale	-$2.57M	-311K	-100%	$8.25	0	16 Aug 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FHTX	Stock Option (right to buy)	Options Exercise	$0	-311K	-100%	$0.00^*	0	16 Aug 2023	Common Stock	311K	$3.72	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until fully vested.